PMVP PMV Pharmaceuticals Inc

Price (delayed)

$1.615

Market cap

$83.08M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.33

Enterprise value

$47.63M

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. ...

Highlights
The EPS is up by 18% year-on-year and by 8% since the previous quarter
The company's net income rose by 12% YoY and by 6% QoQ
The quick ratio is down by 24% YoY but it is up by 13% QoQ
PMVP's equity is down by 8% year-on-year and by 6% since the previous quarter

Key stats

What are the main financial stats of PMVP
Market
Shares outstanding
51.44M
Market cap
$83.08M
Enterprise value
$47.63M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.39
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$65.1M
EBITDA
-$64.02M
Free cash flow
-$58.23M
Per share
EPS
-$1.33
Free cash flow per share
-$1.13
Book value per share
$4.13
Revenue per share
$0
TBVPS
$4.6
Balance sheet
Total assets
$236.88M
Total liabilities
$24.2M
Debt
$13.02M
Equity
$212.68M
Working capital
$190.4M
Liquidity
Debt to equity
0.06
Current ratio
16.79
Quick ratio
16.48
Net debt/EBITDA
0.55
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-26.2%
Return on equity
-29.1%
Return on invested capital
-33.1%
Return on capital employed
-29%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

PMVP stock price

How has the PMV Pharmaceuticals stock price performed over time
Intraday
2.22%
1 week
-3.87%
1 month
0.31%
1 year
-75.46%
YTD
-47.9%
QTD
-0.31%

Financial performance

How have PMV Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$76.87M
Net income
-$65.1M
Gross margin
N/A
Net margin
N/A
The company's net income rose by 12% YoY and by 6% QoQ
PMVP's operating income is up by 4.1% from the previous quarter and by 3.8% YoY

Growth

What is PMV Pharmaceuticals's growth rate over time

Valuation

What is PMV Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.39
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS is up by 18% year-on-year and by 8% since the previous quarter
PMVP's price to book (P/B) is 58% less than its last 4 quarters average of 0.9
PMVP's equity is down by 8% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is PMV Pharmaceuticals business performance
PMV Pharmaceuticals's ROIC has increased by 24% YoY and by 15% from the previous quarter
The company's return on equity rose by 4% QoQ
The return on assets has increased by 4% since the previous quarter

Dividends

What is PMVP's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for PMVP.

Financial health

How did PMV Pharmaceuticals financials performed over time
The current ratio has contracted by 24% YoY but it has grown by 14% from the previous quarter
The quick ratio is down by 24% YoY but it is up by 13% QoQ
The debt is 94% smaller than the equity
PMVP's equity is down by 8% year-on-year and by 6% since the previous quarter
The debt has declined by 3.4% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.